Authors: ONGPIPATTANAKUL B NGUYEN T ZIONCHECK TF WONG R OSAKA G DEGUZMAN L LEE WP

Citation: B. Ongpipattanakul et al., DEVELOPMENT OF TRICALCIUM PHOSPHATE AMYLOPECTIN PASTE COMBINED WITH RECOMBINANT HUMAN TRANSFORMING-GROWTH-FACTOR BETA-1 AS A BONE DEFECT FILLER/, Journal of biomedical materials research, 36(3), 1997, pp. 295-305

Authors: MORDENTI J OSAKA G GARCIA K THOMSEN K LICKO V MENG G

Citation: J. Mordenti et al., PHARMACOKINETICS AND INTERSPECIES SCALING OF RECOMBINANT HUMAN FACTOR-VIII, Toxicology and applied pharmacology, 136(1), 1996, pp. 75-78

Authors: ZAPATA G RIDGWAY JBB MORDENTI J OSAKA G WONG WLT BENNETT GL CARTER P

Citation: G. Zapata et al., ENGINEERING LINEAR F(AB')2 FRAGMENTS FOR EFFICIENT PRODUCTION IN ESCHERICHIA-COLI AND ENHANCED ANTIPROLIFERATIVE ACTIVITY, Protein engineering, 8(10), 1995, pp. 1057-1062

Authors: RODRIGUES ML PRESTA LG KOTTS CE WIRTH C MORDENTI J OSAKA G WONG WLT NUIJENS A BLACKBURN B CARTER P

Citation: Ml. Rodrigues et al., DEVELOPMENT OF A HUMANIZED DISULFIDE-STABILIZED ANTI-BETA-P185(HER2) FV-BETA-LACTAMASE FUSION PROTEIN FOR ACTIVATION OF A CEPHALOSPORIN DOXORUBICIN PRODRUG, Cancer research, 55(1), 1995, pp. 63-70